Clinical trials: Treatment Interruption
- Condition Treatment Interruption
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Thighs Circumferential Reduction, Subcutaneous Fat Cell Disruption
Effect of the XP1100RF Therapy on Thighs Circumference Reduction
This study was designed to demonstrate safety and efficacy of the XP1100RF for non-invasive temporary reduction of thighs circumference by disruption of adipocyte cells.
- Trial name
- NCT02527369
- Testing
- XP1100RF
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- BTL Industries Ltd.